PT Kalbio Global Medika is Officially One of OIC Network Laboratories
COMSTECH OIC holds the internship or fellowship program for the students or scholars who are the citizens of OIC member states. Regarding to this fellowship program for research and advance training in virology and vaccine technologies, COMSTECH OIC established OIC-Center of Excellence (CoE) Network Laboratories. The network laboratories consists of laboratories from multiple insitutes and biopharmaceutical industries, such as Padjajaran University, Airlangga University, Indonesian University, Gadjah Mada University, National Research and Innovation Agency (BRIN), PT Biofarma, PT Kalbio Global Medika (KGM), PT Etana Biotechnologies Indonesia, and PT Dexa Medica.
On 15 Sep 2022, COMSTECH OIC held opening of COMSTECH-OIC Fellowship Program and Soft Launching of OIC-CoE Network Laboratories at Indonesian Ministry of Health (MOH) Building, Jakarta. On this event, PT Kalbio Global Medika was represented by Mr. Sie Djohan, CEO of KGM (Fourth Right).
KGM at a Glance
Kalbio Global Medika (KGM) is one of the first and the pioneer of biopharmaceuticals in Indonesia, established in 2014 and inaugurated officially in 2018 by the President of the Republic of Indonesia, Ir. Joko Widodo. KGM is part of the Kalbe Group, a subsidiary of PT Kalbe Genexine Biologics (KGbio), which is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside US/Canada, Western Europe, and China. KGM is an Innovative CDMO, equipped with CMC and scale-up capabilities plugged into Boston biotech ecosystem and state-of-the-art facility to enhance efficiency and productivity. With API manufacturing, formulation, fill and finish capabilities of biosimilar and novel biologics, averaging 10 million units of syringes, cartridges, and vials, KGM supplies local and international markets.